GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Share News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: new Imperial Innovations chairman dips in

Tue, 21st Jun 2016 09:25

(ShareCast News) - Imperial Innovations' chairman designate took the opportunity to buy shares in the company after they were hit by disappointing news about one of the company's investments.David Newlands, who is set to become non-executive chairman on 1 August, bought his first 100,000 shares at an average price of 421.1p each.Imperial Innovations' shares fell from above 449p to as low as results from a clinical study on Circassia Pharmaceuticals' cat allergy treatment's showed it failed to perform against a placebo.In the study, both treatment regimens and placebo greatly - and equally - reduced subjects' combined allergy symptom and rescue medication use score from baseline."Although these results are disappointing, we continue to be supportive long-term shareholders in Circassia," said Imperial CEO Russ Cummings. "The experienced management team have diversified the business since its IPO in 2014."Also on Tuesday, specialist engineer TP Group rallied after several board members dipped into the market.CEO Phil Cartmell bought 424,000 shares at a price of 3.375p each, CFO Derren Stroud bought 200,000 at close to 3.85p, while executive director Simon Kings bought 150,000 at an average price of 3.46p per share. Top Director BuysImperial Innovations Group (IVO)Director name: Newlands,DavidAmount purchased: 100,000 @ 421.10pValue: £421,100.00Chemring Group (CHG)Director name: Dayan,DanielAmount purchased: 60,500 @ 115.00pValue: £69,575.00Ekf Diagnostics Holdings (EKF)Director name: Mills,Christopher H BAmount purchased: 532,781 @ 11.50pValue: £61,269.82Lxb Retail Properties (LXB)Director name: Webb,Stephen JohnAmount purchased: 75,661 @ 66.00pValue: £49,936.26Uil Limited (di) (UTL)Director name: Samuel,ChristopherAmount purchased: 20,000 @ 117.00pValue: £23,400.00Wolseley (WOS)Director name: Lopez,PilarAmount purchased: 600 @ 3,752.49pValue: £22,514.94Stilo International (STL)Director name: Ashman,DavidAmount purchased: 300,000 @ 5.75pValue: £17,250.00Tp Group (TPG)Director name: Cartmell,PhilipAmount purchased: 424,000 @ 3.38pValue: £14,310.00Uil Limited (di) (UTL)Director name: Shillson,DavidAmount purchased: 8,500 @ 117.00pValue: £9,945.00Sirius Real Estate Ltd. (SRE)Director name: Coombs,Andrew Amount purchased: 16,468 @ € 0.53Value: € 8,728.04Sirius Real Estate Ltd. (SRE)Director name: Marks,Alistair Amount purchased: 16,092 @ € 0.53Value: € 8,528.76Tp Group (TPG)Director name: Kings,Simon J NicholsonAmount purchased: 150,000 @ 3.46pValue: £5,190.00Tp Group (TPG)Director name: Stroud,DerrenAmount purchased: 93,220 @ 3.85pValue: £3,588.97Tp Group (TPG)Director name: Stroud,DerrenAmount purchased: 56,780 @ 3.83pValue: £2,171.83Tp Group (TPG)Director name: Stroud,DerrenAmount purchased: 50,000 @ 3.83pValue: £1,912.50Centaur Media (CAU)Director name: Vidler ,AndriaAmount purchased: 320 @ 46.88pValue: £150.02Pennon Group (PNN)Director name: Loughlin,ChristopherAmount purchased: 18 @ 828.50pValue: £149.13Pennon Group (PNN)Director name: Davy ,Susan Amount purchased: 15 @ 828.50pValue: £124.27Top Director SellsBioquell (BQE)Director name: Mills,Christopher Options sale of shares: 6,305,000 @ 200.00pValue: £12,610,000.00Bioquell (BQE)Director name: Roller,Michael R DOptions sale of shares: 962,200 @ 200.00pValue: £1,924,400.00Bioquell (BQE)Director name: Adams,Nicholas M TOptions sale of shares: 513,697 @ 200.00pValue: £1,027,394.00Bioquell (BQE)Director name: Constantine,SimonAmount purchased: 235,000 @ 200.00pValue: £470,000.00Londonmetric Property (LMP)Director name: Jones,AndrewAmount purchased: 74,879 @ 158.20pValue: £118,458.58Londonmetric Property (LMP)Director name: Beresford,ValentineAmount purchased: 41,798 @ 158.20pValue: £66,124.44Londonmetric Property (LMP)Director name: Stirling,MarkAmount purchased: 41,798 @ 158.20pValue: £66,124.44Londonmetric Property (LMP)Director name: McGann,MartinAmount purchased: 37,039 @ 158.20pValue: £58,595.70
More News
24 Sep 2021 11:10

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

Read more
5 Jan 2017 16:45

Imperial Innovations completes quick-change to Touchstone

(ShareCast News) - Imperial Innovations Group announced on Thursday that, further to the shareholder approval received at its AGM on 21 November 2016, the change of the company's name to Touchstone Innovations took effect on 4 January. The AIM-traded firm added that, with effect from 0800 GMT on Thu

Read more
28 Oct 2016 14:18

Imperial Innovations to change name to 'Touchstone'

(ShareCast News) - Imperial Innovations Group announced on Friday that at its annual general meeting on 21 November, it will be seeking shareholder approval to change the name of the company to Touchstone Innovations. The AIM-traded group was originally formed as the technology transfer office for I

Read more
24 Oct 2016 15:04

Imperial Innovations celebrates investment momentum

(ShareCast News) - Imperial Innovations Group noted on Monday that its portfolio company, Veryan Medical, has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D Self-Expanding Stent System. The AIM-traded firm said the MIMICS-2 study is a prospective, multicentre, interventiona

Read more
24 Oct 2016 06:59

Imperial Innovations Says Veryan Completes Clinical Study Enrolment

Read more
13 Oct 2016 08:36

Imperial Innovations' increases investments as pre-tax loss widens

(ShareCast News) - Imperial Innovations' annual pre-tax loss widened while the technology commercialisation and investment company increased investments across its business with universities and a joint venture. For the year ended 31 July, the pre-tax loss widened to £63.1m from £15.1m, last year, w

Read more
6 Oct 2016 15:15

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Oct 2016 15:15

Imperial Innovations shares up on portfolio company progress

(ShareCast News) - Imperial Innovations Group updated the market on Thursday, noting that its portfolio company TopiVert Pharma has announced that the first patients have been dosed in its Phase IIa proof-of-concept study to evaluate the safety, tolerability and efficacy of a rectal formulation of T

Read more
6 Oct 2016 06:31

Imperial Innovations: Topivert Moves To Phase Two Of TOP1288 Study

Read more
3 Oct 2016 15:20

Imperial Innovations sells Permasense portfolio business

(ShareCast News) - AIM-listed Imperial Innovations has sold its portfolio company Permasense to Fortune 500 company Emerson Electric for an initial consideration of £30.6m in cash. Further amounts of up to £10m may be paid in addition, subject to the Permasense business achieving certain performance

Read more
21 Sep 2016 12:23

Imperial Innovations invests £5.1m in new biotech start-up

(ShareCast News) - AIM-listed technology investor Imperial Innovations invested £5.1m in Artios Pharma, a new biotech start-up launched on Wednesday. Imperial Innovations contributed £5.1m to the £25m series A funding round, giving it a 14.9% interest in the new Cambridge- based company. Artios, wh

Read more
19 Aug 2016 09:23

Cambridge University innovation investor raises 75 million pounds

LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital, which commercializes technology and healthcare research from Cambridge University, has raised 75 million pounds ($98 million) from investors, including for the first time Woodford Investment Management. CIC, founded in 2013, has alrea

Read more
12 Jul 2016 06:55

Imperial Innovations Notes Cell Medica Acquisition Of Delenex

Read more
6 Jul 2016 06:41

Imperial Innovations Takes Part In New Funding For Econic Technologies

Read more
30 Jun 2016 11:39

Imperial Innovations Says PsiOxus Signs Deal With Bristol-Myers Squibb

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.